Dr. Mark Burkard, a physician-scientist at the University of Wisconsin Carbone Cancer Center, is interested in targeted therapy directed at protein kinases.

His laboratory seeks to link therapies with their targets within cancer cells using genetic tools, and to identify patients whose cancers are most likely to benefit from particular drugs. These studies will be used to inform clinical development of novel agents. Dr. Burkard is part of the breast cancer disease oriented working group at the Cabone Cancer Center.